Amneal Pharmaceuticals, Inc. (AMRX) Financials

AMRX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 3.5 billion 3.5 billion
2023-09-30 3.7 billion 3.5 billion
2023-06-30 3.7 billion 3.5 billion
2023-03-31 3.6 billion 3.5 billion

AMRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 104.1 million 6.0 million
2023-09-30 67.9 million 6.7 million
2023-06-30 -23.6 million 6.6 million
2023-03-31 128.0 million 7.6 million

AMRX Net Income

No data available :(

AMRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 91.5 million - 109.9 million
2023-09-30 86.9 million - 115.3 million
2023-06-30 109.3 million 2.6 billion 118.6 million
2023-03-31 144.7 million 2.6 billion 121.4 million

AMRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 243.7 million
2023-09-30 159.7 million
2023-06-30 154.9 million
2023-03-31 152.1 million

AMRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 31.7 million 46.6 million 109.0 million -
2023-09-30 13.5 million 42.3 million 113.0 million -
2023-06-30 12.3 million 38.6 million 105.6 million -
2023-03-31 11.7 million 40.3 million 102.1 million -

AMRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 617.0 million 427.2 million
2023-09-30 620.0 million 387.5 million
2023-06-30 599.0 million 379.0 million
2023-03-31 557.5 million 379.4 million

AMRX

Price: $5.87

52 week price:
1.40
6.46

Earnings Per Share: -0.48 USD

P/E Ratio: 92

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 1.8 million

Market Capitalization: 1.7 billion

Links: